<DOC>
	<DOCNO>NCT00960986</DOCNO>
	<brief_summary>The purpose study assess nausea severity response four different drug dose strategy Duloxetine ( 30 mg food , 60 mg food , 30 mg without food , 60 mg without food ) Korean patient major depressive disorder ( MDD ) .</brief_summary>
	<brief_title>A Duloxetine Dosing Strategy Study Korean Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>For female childbearing potential test negative pregnancy time enrollment base urine pregnancy test agree use reliable method birth control study 1 month follow last dose study drug . 17item Hamilton Depression Rating Scale ( HAMD17 ) total score &gt; 15 Screening Randomization Have sign inform consent document ( ICD ) Have level understanding sufficient provide inform consent communicate investigator site personnel Are judge reliable agree keep appointment clinic visit , test , procedure require protocol Patients must meet Diagnostic Statistical Manual Mental Disordersfourth editiontext revision ( DSMIVTR ) criteria Major Depressive Disorder ( MDD ) . The Mini International Neuropsychiatric Interview ( MINI ) use establish diagnosis exclude psychiatric illness . Treatment within last 30 day drug receive regulatory approval indication time study entry Have current primary Axis I disorder MDD Have previous diagnosis bipolar disorder , schizophrenia , psychotic disorder Lack response current episode major depression two adequate course antidepressant therapy clinically appropriate dose minimum 4 week , judgment investigator , patient meet criteria treatmentresistant depression Have history lack response , time , adequate trial duloxetine ( defined treatment least 60 mg/day duloxetine minimum 4 week ) Presence Axis II disorder , judgment investigator , would interfere study compliance DSMIVTRdefined history substance abuse dependence within past 6 month , exclude nicotine caffeine Patients judge serious suicidal risk opinion investigator and/or score â‰¥3 Item 3 ( suicide ) HAMD17 Serious medical illness clinically significant laboratory abnormality , judgment investigator , likely require intervention/hospitalization/excluded medication course study Note : Patients acute liver injury ( hepatitis ) severe ( ChildPugh Class C ) cirrhosis exclude Have acute chronic medical illness main symptom nausea gastrointestinal discomfort take medication know major gastric effect would interfere nausea rating . Electroconvulsive therapy ( ECT ) Transcranial Magnetic Stimulation ( TMS ) within past year Taking exclude medication within 7 day prior Randomization . Treatment monoamine oxidase inhibitor ( MAOI ) within 14 day prior Randomization potential need use MAOI within 5 day discontinuation study drug . Treatment fluoxetine within 30 day prior Randomization . Frequent and/or severe allergic reaction multiple medication know hypersensitivity duloxetine . Abnormal thyroid stimulate hormone ( TSH ) concentration . Note : Participants diagnose hyperthyroidism hypothyroidism treat stable dose thyroid supplement least past 3 month , medically appropriate TSH concentration , clinically euthyroid , allow enroll study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>